Perrigo Company PublicCompany Share Price Today
(NASDAQ: PRGO)

Name: Perrigo Company PublicCompany Share Price Today (NASDAQ: PRGO) - Perrigo Company PublicCompany Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Perrigo Company PublicCompany share price is $29.47 & ₹2,562.98 as on 6 Mar 2025, 2.30 'hrs' IST

$29.47

▲

0.18

(0.61%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Perrigo Company PublicCompany share price in Dollar and Rupees. Guide to invest in Perrigo Company PublicCompany stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Perrigo Company PublicCompany, along with analyst recommendations, forecasts, and comprehensive financials.

Perrigo Company PublicCompany share price movements

Today's Low: $28.87
Today's High: $29.54
$29.47
2.04%
Downside
Day's Volatility :2.25%
Upside
0.22%
52 Weeks Low: $23.14
52 Weeks High: $33.46
$29.47
21.48%
Downside
52 Weeks Volatility :30.83%
Upside
11.91%

Perrigo Company PublicCompany (PRGO) Returns

Period	Perrigo Company Public Limited Company	Sector (Health Care)	Index (Russel 2000)
3 Months	3.02%	2.1%	0.0%
6 Months	3.94%	-4.1%	0.0%
1 Year	4.27%	2.2%	0.0%
3 Years	-18.91%	11.8%	-11.6%

Perrigo Company PublicCompany (PRGO) Key Statistics

in dollars & INR

Previous Close	$29.29
Open	$29.22
Today's High	$29.535
Today's Low	$28.87
Market Capitalization	$4.0B
Today's Volume	$990.4K
52 Week High	$33.455
52 Week Low	$23.14
Revenue TTM	$4.4B
EBITDA	$640.5M
Earnings Per Share (EPS)	$-1.17
Dividend Yield	4.0%
Profit Margin	-3.93%
Quarterly Earnings Growth YOY	-0.64%
Return On Equity TTM	-3.54%

How to invest in Perrigo Company PublicCompany Stock (PRGO) from India?

It is very easy for Indian residents to invest directly in Perrigo Company PublicCompany from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Perrigo Company PublicCompany stock in both Indian Rupees (INR) and US Dollars (USD). Search for Perrigo Company PublicCompany or PRGO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Perrigo Company PublicCompany or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Perrigo Company PublicCompany shares which would translate to 0.030 fractional shares of Perrigo Company PublicCompany as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Perrigo Company PublicCompany, in just a few clicks!

Returns in Perrigo Company PublicCompany (PRGO) for Indian investors in Rupees

The Perrigo Company PublicCompany stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Perrigo Company PublicCompany investment value today

Current value as on today

₹1,09,876

Returns

₹9,876

(+9.88%)

Returns from Perrigo Company PublicCompany Stock

₹4,913 (+4.91%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Perrigo Company PublicCompany (PRGO)

33%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Perrigo Company PublicCompany Stock from India on INDmoney has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Perrigo Company PublicCompany

Vanguard Group Inc
10.90%
BlackRock Inc
9.71%
T. Rowe Price Associates, Inc.
5.75%
Dimensional Fund Advisors, Inc.
5.12%
State Street Corp
5.05%
DePrince Race & Zollo Inc
3.34%

Analyst Recommendation on Perrigo Company PublicCompany

Buy

90%Buy

10%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Perrigo Company PublicCompany(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Perrigo Company PublicCompany Stock (PRGO)

What analysts predicted

Upside of 17.41%

Target:

$34.60

Current:

$29.47

Insights on Perrigo Company PublicCompany Stock (Ticker Symbol: PRGO)

Price Movement
In the last 7 days, PRGO stock has moved up by 17.6%
Increasing Revenue
Revenue is up for the last 3 quarters, 1.06B → 1.13B (in $), with an average increase of 3.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -21.0M → -44.5M (in $), with an average decrease of 111.9% per quarter
PRGO vs ITCI (1 yr)
In the last 1 year, Intra-cellular Therapies, Inc. has given 97.0% return, outperforming this stock by 89.6%
PRGO vs ITCI (3 yr)
In the last 3 years, Intra-cellular Therapies, Inc. has given 138.2% return, outperforming this stock by 159.5%
Price to Sales
ForPRGO every $1 of sales, investors are willing to pay $0.9, whereas for Intra-cellular Therapies, Inc., the investors are paying $19.9 for every $1 of sales.

PRGO Perrigo Company PublicCompany Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$4.8B	↑ 2.23%
Net Income	$146.1M	↑ 11.53%
Net Profit Margin	3.02%	↑ 0.25%

	FY20	Y/Y Change
Revenue	$5.1B	↑ 4.67%
Net Income	$-162.6M	↓ 211.29%
Net Profit Margin	-3.21%	↓ 6.23%

	FY21	Y/Y Change
Revenue	$4.1B	↓ 18.26%
Net Income	$-130.9M	↓ 19.5%
Net Profit Margin	-3.16%	↑ 0.05%

	FY22	Y/Y Change
Revenue	$4.5B	↑ 7.56%
Net Income	$-130.9M	↑ 0.0%
Net Profit Margin	-2.94%	↑ 0.22%

	FY23	Y/Y Change
Revenue	$4.7B	↑ 4.58%
Net Income	$-12.7M	↓ 90.3%
Net Profit Margin	-0.27%	↑ 2.67%

	FY24	Y/Y Change
Revenue	$4.4B	↓ 6.06%
Net Income	$-171.8M	↑ 1252.76%
Net Profit Margin	-3.93%	↓ 3.66%

	Q3 FY23	Q/Q Change
Revenue	$1.1B	↓ 5.81%
Net Income	$14.2M	↑ 69.05%
Net Profit Margin	1.26%	↑ 0.56%

	Q4 FY23	Q/Q Change
Revenue	$1.2B	↑ 2.95%
Net Income	$-32.3M	↓ 327.46%
Net Profit Margin	-2.79%	↓ 4.05%

	Q1 FY24	Q/Q Change
Revenue	$1.1B	↓ 6.45%
Net Income	$4.1M	↓ 112.69%
Net Profit Margin	0.38%	↑ 3.17%

	Q2 FY24	Q/Q Change
Revenue	$1.1B	↓ 1.53%
Net Income	$-105.7M	↓ 2678.05%
Net Profit Margin	-9.92%	↓ 10.3%

	Q3 FY24	Q/Q Change
Revenue	$1.1B	↑ 2.05%
Net Income	$-21.0M	↓ 80.13%
Net Profit Margin	-1.93%	↑ 7.99%

	Q4 FY24	Q/Q Change
Revenue	$1.1B	↑ 4.67%
Net Income	$-44.5M	↑ 111.9%
Net Profit Margin	-3.91%	↓ 1.98%

	FY19	Y/Y Change
Profit	$1.8B	↓ 3.18%

	FY20	Y/Y Change
Profit	$1.8B	↑ 2.36%

	FY21	Y/Y Change
Profit	$1.4B	↓ 21.98%

	FY22	Y/Y Change
Profit	$1.5B	↑ 2.77%

	FY23	Y/Y Change
Profit	$1.7B	↑ 15.46%

	FY24	Y/Y Change
Profit	$1.5B	↓ 8.19%

	Q3 FY23	Q/Q Change
Profit	$411.2M	↓ 3.93%

	Q4 FY23	Q/Q Change
Profit	$427.3M	↑ 3.92%

	Q1 FY24	Q/Q Change
Profit	$358.1M	↓ 16.19%

	Q2 FY24	Q/Q Change
Profit	$395.0M	↑ 10.3%

	Q3 FY24	Q/Q Change
Profit	$404.4M	↑ 2.38%

	Q4 FY24	Q/Q Change
Profit	$385.9M	↓ 4.57%

	FY19	Y/Y Change
Operating Cash Flow	$387.8M	↓ 34.6%
Investing Cash Flow	$-596.1M	↑ 370.11%
Financing Cash Flow	$1.8M	↓ 100.31%

	FY20	Y/Y Change
Operating Cash Flow	$636.2M	↑ 64.05%
Investing Cash Flow	$-187.8M	↓ 68.5%
Financing Cash Flow	$-181.1M	↓ 10161.11%

	FY21	Y/Y Change
Operating Cash Flow	$156.3M	↓ 75.43%
Investing Cash Flow	$1.3B	↓ 779.34%
Financing Cash Flow	$-178.7M	↓ 1.33%

	FY22	Y/Y Change
Operating Cash Flow	$307.3M	↑ 96.61%
Investing Cash Flow	$-2.0B	↓ 253.52%
Financing Cash Flow	$421.6M	↓ 335.93%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$124.5M	↑ 135.35%
Investing Cash Flow	$-30.7M	↑ 597.73%
Financing Cash Flow	$-43.3M	↓ 10.91%

Perrigo Company PublicCompany Technicals Summary

Sell

Neutral

Buy

Perrigo Company PublicCompany is currently in a neutral trading position according to technical analysis indicators.

Perrigo Company PublicCompany (PRGO) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Perrigo Company Public Limited Company	16.74%	3.94%	4.27%	-18.91%	-40.09%
Intra-cellular Therapies, Inc.	3.42%	81.22%	98.76%	146.55%	588.92%
Haleon Plc Spon Ads	12.55%	3.39%	28.09%	43.99%	43.99%
Zoetis Inc.	-1.19%	-8.94%	-7.43%	-9.67%	30.97%
Neurocrine Biosciences Inc.	-24.64%	-6.68%	-14.47%	28.61%	27.88%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Perrigo Company Public Limited Company	2818.0	NA	1.14	2.97	-0.04	0.02	0.04	31.64
Intra-cellular Therapies, Inc.	NA	NA	0.0	0.13	-0.09	-0.07	NA	10.81
Haleon Plc Spon Ads	26.68	26.68	1.5	0.36	0.09	0.04	0.02	1.8
Zoetis Inc.	31.17	31.17	3.01	6.07	0.51	0.15	0.01	10.64
Neurocrine Biosciences Inc.	34.8	34.8	0.27	6.47	0.14	0.1	NA	26.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Perrigo Company Public Limited Company	Buy	$4.0B	-40.09%	2818.0	-3.93%
Intra-cellular Therapies, Inc.	Buy	$14.0B	588.92%	NA	-10.97%
Haleon Plc Spon Ads	Buy	$48.2B	43.99%	26.68	12.84%
Zoetis Inc.	Buy	$76.1B	30.97%	31.17	26.86%
Neurocrine Biosciences Inc.	Buy	$11.3B	27.88%	34.8	14.49%

Perrigo Company PublicCompany Dividend announcements

Perrigo Company PublicCompany Dividends March, 2025
In the quarter ending March,2025. Perrigo Company PublicCompany has declared dividend of $0.29

About Perrigo Company PublicCompany

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Organization	Perrigo Company PublicCompany
Employees	0
CEO	Mr. Ronald C. Janish
Industry	Health Technology

Management People of Perrigo Company PublicCompany

Name	Title
Mr. Ronald C. Janish	Chief Transformation Officer and Executive VP of Global Operations & Supply Chain
Mr. Shannon Hukill	Senior Director of Technical Operations
Ms. Mary Reilly-Brest	Director of Global Organizational and Human Resource Development
Mr. Robert Willis	Chief Human Resources Officer & Executive VP

Important FAQs about investing in PRGO Stock from India :

What is Perrigo Company PublicCompany share price today?

Perrigo Company PublicCompany share price today stands at $29.47, Open: $29.22 ; Previous Close: $29.29 ; High: $29.54 ; Low: $28.87 ; 52 Week High: $33.46 ; 52 Week Low: $23.14.

The stock opens at $29.22, after a previous close of $29.29. The stock reached a daily high of $29.54 and a low of $28.87, with a 52-week high of $33.46 and a 52-week low of $23.14.

Can Indians buy Perrigo Company PublicCompany shares?

Yes, Indians can invest in the Perrigo Company PublicCompany (PRGO) from India.

With INDmoney, you can buy Perrigo Company PublicCompany at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Perrigo Company PublicCompany at zero transaction cost.

How can I buy Perrigo Company PublicCompany shares from India?

It is very easy to buy Perrigo Company PublicCompany from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Perrigo Company PublicCompany (PRGO) be purchased?

Yes, you can buy fractional shares of Perrigo Company PublicCompany with INDmoney app.

What are the documents required to start investing in Perrigo Company PublicCompany stocks?

To start investing in Perrigo Company PublicCompany, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.